https://www.ncbi.nlm.nih.gov/pubmed/30802651/Clin Microbiol Infect. 2019 Feb 22. pii: S1198-743X(19)30086-2. doi: 10.1016/j.cmi.2019.02.020. [Epub ahead of print]
Lyme Disease Overdiagnosis in a Large Healthcare System: A Population-based, Retrospective Study.
Webber BJ1, Burganowski RP2, Colton L3, Escobar JD3, Pathak SR4, Gambino-Shirley KJ3.
To evaluate the impact of false positive IgM immunoblots on Lyme disease treatment and case reporting in a large healthcare system.
We obtained results of all Lyme disease serologic tests ordered at U.S. Air Force healthcare facilities in the United States between January 2013 and December 2017. We conducted chart reviews to adjudicate positive IgM immunoblots (from two-tier and independent testing) as true positives or false positives using established criteria, and we assessed whether these cases were reported to the U.S. Department of Defense surveillance system.
Of the 18,410 serum tests (17,058 immunoassays and 1,352 immunoblots) performed on 15,928 unique persons, 249/1,352 (18.4%) IgM immunoblots were positive. After excluding repeat tests, insufficiently documented cases, and subjects with a history of Lyme disease, 212 positive IgM immunoblot cases were assessed. A total of 113/212 (53.3%) were determined to be false positives. Antibiotics were prescribed for Lyme disease for 97/99 (98.0%) subjects with a true positive test and 91/113 (80.5%) subjects with a false positive test. The number of false positive cases reported to the surveillance system was identical to the number of unreported true positive cases (n=44).
Lyme disease serological tests were overutilized in a large healthcare system, and positive results were frequently misinterpreted, leading to misdiagnosis and widespread antibiotic misuse. Underreporting of true positive cases was offset by overreporting of false positive cases, suggesting that the discrepancy between the reported incidence and true incidence of Lyme disease may not be as significant as previously assumed.
Published by Elsevier Ltd.
Borrelia Burgdorferi; Clinical Laboratory Techniques; Epidemiology; False Positive Reactions; Lyme Disease; Medical Overuse; Predictive Value of Tests; Tick-Borne Diseases
PMID: 30802651 DOI: 10.1016/j.cmi.2019.02.020
Topics with information and discussion about published studies related to Lyme disease and other tick-borne diseases.
1 post • Page 1 of 1